Fluoroquinolones and QT Prolongation

Yap YG Camm AJ . Drug induced QT prolongation and torsades de pointes. Heart 2003;89(11):1363–72.

Schoepp G . Medication forum. Pharm Pract 2001;17(10):30–1.

Jayasinghe R Kovoor P . Drugs and the QTc interval. Australian Prescriber 2002;25(3):63–5.

Owens RC Jr . QT prolongation with antimicrobial agents. Drugs 2004;64(10):1091–124.

Crouch MA Limon L Cassano AT . Clinical relevance and management of drug-related QT interval prolongation. Pharmacotherapy 2003;23(7):881–908.

Amankwa K Krishnan SC Tisdale JE . Torsades de pointes associated with fluoroquinolones: importance of concomitant risk factors. Clin Pharmacol Ther 2004;75(3):242–7.

Wolbrette DL . Drugs that cause torsades de pointes and increase the risk of sudden cardiac death. Curr Cardiol Rep 2004;6(5):379–84.

Owens RC Jr . Risk assessment for antimicrobial agent-induced QTc interval prolongation and torsades de pointes. Pharmacotherapy 2001;21(3):301–19.

Roden DM . Drug-induced prolongation of the QT interval. N Engl J Med 2004;350(10):1013–22.

Woosley RL . Drugs that prolong the QT interval and/or induce torsades de pointes. Arizona Center for Education and Research on Therapeutics. Available: www.torsades.org (accessed March 14, 2005).

Al-Khatib SM LaPointe Allen NM Kramer JM Califf RM . What clinicians should know about the QT interval. JAMA 2003;289(16):2120–7.

Viskin S Justo D Halkin A Zeltser D . Long QT syndrome caused by noncardiac drugs. Prog Cardiovasc Dis 2003;45(5):415–27.

Rosser WW Pennie RA , Pilla NJ and the Anti-infective Review Panel. Anti-infective guidelines for community-acquired infections. Toronto, ON: MUMS Guideline Clearinghouse; 2005.